Navigation Links
KV Pharmaceutical Forms Licensing Partnership with Gedeon Richter
Date:6/18/2009

ST. LOUIS and BUDAPEST, Hungary, June 18 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVa/KVb) today announced that it has entered into an agreement with Gedeon Richter, Plc. of Budapest, Hungary, and jointly with Gedeon Richter USA for licensing rights to certain of KV's technologies and products in Women's Health. The agreement expands the parties' relationship and allows Gedeon Richter rights to manufacture and distribute certain of KV's proprietary technologies and products in its territories, including the European Union. KV Pharmaceutical will receive undisclosed milestones and royalties for products developed under the terms of the agreement.

The agreement also provides for the development of additional products in the future. KV retains the rights to the products and technology in the US.

David Van Vliet, interim CEO at KV Pharmaceutical Company said, "KV Pharmaceutical and Gedeon Richter have for many years enjoyed an excellent relationship and business collaboration and we are very pleased to extend it in this fashion. We believe this agreement allows both Richter and KV to offer additional enhanced products to more completely serve physicians and their patients."

Erik Bogsch, CEO of Gedeon Richter Plc. commented: "I am pleased to inform you about the extended cooperation between the two companies. We consider this agreement as an important step towards our strategy acquiring projects or products with high added value nature, as it allows us to enhance our existing female healthcare portfolio, not only in our traditional markets, but in all the EU member states. Present in-licensed products, as well as Richter's future proprietary development products will be produced at Richter's facilities based on KV's excellent technology platform."

About KV Pharmaceutical Company

KV Pharmaceutical Company is a fully integrated specialty pharmaceutical comp
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)...ides for an unprecedented expansion of federally-f... not for preserving and protecting human life? If ...armaine Yoest ,, WASHINGTON, Nov. 21 /PRNewsw...n President and CEO Dr. Charmaine Yoest responded ...ollowing statement: ,, "This was a pro-abortio...
(Date:11/21/2009)...sed medical credentialing software company Intelli...partnerhsip with Amerinet, Inc., the leading healt...lp to transform quality care within the healthcare...er 21, 2009 -- ISG Group, LLC, doing business as I...th Amerinet Inc., a leading national healthcare gr...
(Date:11/21/2009)...od Group ask whether there is a secret to ,alcohol... London, UK (PRWEB) November 21, 2... three of the adult UK population drinking enough ...ated liver disease*, it is hardly a surprise that ...ogrammes and residential centres for help. However...
(Date:11/20/2009)...20 Following a recall by Unilever ...om sale Shedd,s Country Crock ® Side Dishes D...ock ® Side Dishes DELUXE Four Cheese Pasta du...llowing code dates and UPCs are affected: ,, S...ddar Broccoli Rice 21 oz, UPC 027400218316, Best B...
(Date:11/20/2009)..., November 20 Cardio Vas...CVSLMEDICAL.COM , a leading,developer of advanced ... that,the company,s Board of Directors has decided... and the Far East for its proprietary next-generat...plasty (PCTA) procedures. , Cardio Vascul...
Breaking Medicine News(10 mins):Health News:Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill 2Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2
...th plan in Indiana experienced a 50 percent member... INDIANAPOLIS, May 30 MDwise employees today are,...old, not-for-profit,Indiana managed health care pl...yee base by 182 percent -- going from just,over 50...
...courages everyone to learn CPR/AED, WASHINGTON, M...ore than 166,000 people in this country every year...uffer sudden cardiac arrest,die before reaching a ...st waiting for help to arrive, many,thousands of l...
...- Mayo Clinic researchers have developed an animal... tumor suppressor genes, p16 and p19, in the aging...re expressed at increased levels as humans and mic... stops that process. , The findings, to be publis...
...30 Stronger health,systems, improved maternal and...d other infectious diseases are essential to Afric...today., These health priorities were highlighted ...organizations., Under the theme, "Towards a vibra...
...men tend to whet men,s sexual appetite. But stimul...arch says there,s more than meets the eye. A recen...handled lingerie sought immediate gratificationeve...ound that the desire for immediate rewards increas...
...quipment weight makes for temporary height loss, s...ws) -- Repetitive blocking and the weight of helme...t in a temporary loss of height for some football ...rcent of their height in a normal day. Fortunately...
Other Medicine News:Health News:MDwise Enrollment Exceeds 300,000 Members 2Health News:National CPR/AED Awareness Week 2Health News:Stronger Health Systems and Better Maternal Health Critical to African Development, Japan Summit Affirms 2Health News:Stronger Health Systems and Better Maternal Health Critical to African Development, Japan Summit Affirms 3Health News:Football Can Shrink Players 2
(Date:11/20/2009)... , PRINCETON, N.J., Nov. 20 /PRNewswire-Firs...X) (Soligenix or the Company), formerly known as D...pany, announced today that it has formed a consort...RiVax(TM) and other rapidly acting vaccines. Solig...al Institute of Allergy and Infectious Diseases (N...
(Date:11/19/2009)... , LYON, France, Nov. 19 In re...pplying dangerous and illegal medicines, Operation...d by INTERPOL and the World Health Organization,s ... Taskforce (IMPACT) to highlight the dangers of bu...initiative resulted in a series of arrests and the...
(Date:11/19/2009)... , MOUNTAIN VIEW, Calif., Nov. 19 /PRNewswire-...: ALXA ) announced today that its corporate prese...l Piper Jaffray Health Care Conference on Wednesda...e presentation will be webcast from The New York P...homas B. King, Alexza President and CEO. ,, T...
Breaking Medicine Technology:Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3Childhood Brain Cancer Causes Other Long Term Problems 60506 1Childhood Brain Cancer Causes Other Long Term Problems 60506 2Asian Optical Retailers Upbeat about 2010 60503 1Asian Optical Retailers Upbeat about 2010 60503 2Asian Optical Retailers Upbeat about 2010 60503 3Helmets for Hope Campaign and Gala 60499 1Helmets for Hope Campaign and Gala 60499 2
..., 2007 - Pluristem Life Systems,Inc. (OTCBB:PLRS)...o the commercialization of products for a variety ...ions, announced today that,Pluristem,s PLacenta eX... to have properties that the Company believes give...isease (PD). PLX cells,are Pluristem,s placental-d...
... Improvement in Signs and,Symptoms Of Moderate to ...ents Achieving Disease Remission at One-Year,Mar...r data show nearly,75 percent of patients with mod...g golimumab (CNTO 148) and methotrexate (MTX),expe...ment in,arthritis symptoms (ACR 20). This was acco...
Other Medicine Technology:Pluristem's PLX Cells Demonstrate Potential to Treat Parkinson's,Disease 2Pluristem's PLX Cells Demonstrate Potential to Treat Parkinson's,Disease 3Pluristem's PLX Cells Demonstrate Potential to Treat Parkinson's,Disease 4Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 2Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 3Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 4Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 5
...nded memory capabilities for overnight sleep scree...ygen saturation and pulse rate data, and can opera...s:, ,1. The Model 130 can retain up to 30 min...he device ideally suited for treadmill or other lo...
BCI 3303 Hand-Held Pulse Oximeter w/Rechargeable Battery
... fourth in the Clarity Series is a cost-effective,... with 3 or 5 lead ECG, pace detect/reject, digital...logy, and respiration. A high-resolution electrol...urable traces. An optional recorder (Smiths Medic...
...Management Program is a Windows based, easy-to-use...Held Pulse Oximeter. Using the Smiths Medical PM,...wnloads information collected during sleep screeni...ies, and assists in the Clinician's interpretation...
Medicine Products: